Fuji Pharma Co., Ltd. (TYO:4554)
Japan · Delayed Price · Currency is JPY 1,939.00
+67.00 (3.58%)
Jul 14, 2026, 3:30 PM JST
Fuji Pharma Market Cap
Fuji Pharma has a market cap or net worth of 50.65 billion as of July 14, 2026. Its market cap has increased by 55.54% in one year.
Market Cap
50.65B
Enterprise Value
69.38B
Revenue
57.30B
Ranking
n/a
PE Ratio
19.68
Stock Price
1,939.00
Market Cap Chart
Since December 21, 2005, Fuji Pharma's market cap has increased from 17.38B to 50.65B, an increase of 191.33%. That is a compound annual growth rate of 5.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 50.65B | 9.69% |
| Dec 30, 2025 | 46.17B | 18.77% |
| Dec 30, 2024 | 38.88B | -8.01% |
| Dec 29, 2023 | 42.26B | 70.05% |
| Dec 30, 2022 | 24.85B | -0.36% |
| Dec 30, 2021 | 24.94B | -35.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kissei Pharmaceutical | 169.54B |
| Kaken Pharmaceutical | 144.28B |
| Mochida Pharmaceutical | 110.25B |
| Zeria Pharmaceutical | 90.76B |
| KYORIN Pharmaceutical | 67.63B |
| ASKA Pharmaceutical Holdings | 63.41B |
| Daito Pharmaceutical | 37.32B |
| Koa Shoji Holdings | 32.43B |